Mortality and morbidity of patients with neuroblastoma who survived for more than 10 years after treatment-Niigata Tumor Board Study

Journal of Pediatric Surgery

Volumn 45, Issue 4, 2010, Pages 673-677

  Kubota, Masayuki ^a   Okuyama, Naoki ^a   Hirayama, Yutaka ^a   Asami, Keiko ^b   Ogawa, Atsushi ^b   Watanabe, Akihiro ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Niigata Cancer Center   (Japan)

Author keywords

Late effects; Morbidity; Mortality; Neuroblastoma; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEM CELL TRANSPLANTATION;

ADOLESCENT; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; JAPAN; MALE; MORBIDITY; NEUROBLASTOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; TREATMENT OUTCOME;

EID: 77950489450     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2009.09.002     Document Type: Article

References (13)

1. von Schweinitz D., Hero B., and Berthold F. The impact of surgical radicality on outcome in childhood neuroblastoma. Eur J Pediatr Surg 12 (2002) 402-409
2. Kaneko M., Ohkawa H., and Iwanaka M. Is extensive surgery required for treatment of advanced neuroblastoma?. J Pediatr Surg 32 (1997) 1616-1619
3. Kaneko M., Tsuchida Y., Mugishima H., et al. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification. J Pediatr Hematol Oncol 24 8 (2002) 613-621
4. Kunieda E., Hirobe S., Kaneko T., et al. Patterns of local recurrence after intraoperative radiotherapy for advanced neuroblastoma. Jpn J Clin Oncol 38 8 (2008) 562-566
5. Kushner B.H., Budnick A., Kramer K., et al. Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma. Cancer 107 2 (2006) 417-422
6. van Casteren N.J., van der Linden G.H., Hakvoort-Cammel F.G., et al. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer 52 1 (2009) 108-112
7. Blatt J., Olshan A., Gula M.J., et al. Second malignancies in very-long-term survivors of childhood cancer. Am J Med 93 1 (1992) 57-60
8. Flandin I., Hartmann O., Michon J., et al. Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology. Int J Radiat Oncol Biol Phys 64 5 (2006) 1424-1431
9. Kubota M., Yagi M., Kanada S., et al. Long-term follow-up status of patients with neuroblastoma after undergoing either aggressive surgery or chemotherapy-a single institutional study. J Pediatr Surg 39 9 (2004) 1328-1332
10. Kaneko M., Tsuchida Y., Uchino J., et al. Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma. J Pediatr Hematol Oncol 21 3 (1999) 190-197
11. Zage P.E., Kletzel M., Murray K., et al. Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 51 6 (2008) 747-753
12. Park J.R., Villablanca J.G., London W.B., et al. Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group. Pediatr Blood Cancer 52 1 (2009) 44-50
13. Escobar M.A., Grosfeld J.L., Powell R.L., et al. Long-term outcomes in patients with stage IV neuroblastoma. J Pediatr Surg 41 (2006) 377-381